Algo version: 0.98b
Shenzhen Hepalink is listed at the HKSE Exchange
Shenzhen Hepalink [9989.HK]
HKSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Shenzhen Hepalink stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Shenzhen Hepalink pays dividends. Last time was Tuesday 15th of August 2023 where the investors holding the stock on Wednesday 24th of May 2023 were paid HKD0.11215 per share. Over the last 3 times between 2021 and 2023, Shenzhen Hepalink has paid HKD0.33324 with an average of HKD0.11 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Shenzhen Hepalink 10 years ago, but if you had invested on Wednesday 8th of July 2020 when the price was HKD17.66, you would have made a loss of HKD-14.26 per share or -80.75%

Yes, the average daily trading liquidity for Shenzhen Hepalink is HKD613 548 thousand. You should therefore be able to get in and out of your positions relatively fast.

Shenzhen Hepalink has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.30, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Shenzhen Hepalink to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.